UK Markets open in 7 hrs 55 mins
  • NIKKEI 225

    29,768.06
    +37.26 (+0.13%)
     
  • HANG SENG

    28,698.80
    +24.00 (+0.08%)
     
  • CRUDE OIL

    59.53
    +0.21 (+0.35%)
     
  • GOLD FUTURES

    1,742.30
    -2.50 (-0.14%)
     
  • DOW

    33,800.60
    +297.00 (+0.89%)
     
  • BTC-GBP

    43,879.29
    +440.91 (+1.02%)
     
  • CMC Crypto 200

    1,235.89
    +45.20 (+3.80%)
     
  • Nasdaq

    13,900.19
    +211.39 (+1.54%)
     
  • ^FTAS

    3,949.51
    +17.98 (+0.46%)
     

Global International Reference Pricing Rules Report 2020: The Inter-connectivity of This Pricing Method on a Per Country Basis

Research and Markets
·1-min read

Dublin, March 18, 2021 (GLOBE NEWSWIRE) -- The "Global IRP Rules: International Reference Pricing Global Rules Report" report has been added to ResearchAndMarkets.com's offering.

International Reference Pricing (IRP) is the most common mechanism used by payers around the world to set the price of a drug. The price is derived by benchmarking or referencing prices from a basket of countries.

IRP rules are interconnected and a price reduction in one country may impact diverse countries across different regions. Awareness of the impact of IRP across the life-cycle of a medicine is an absolute must for companies.

The IRP Spotlight reports provide customers with the understanding of the inter-connectivity of this pricing method on a per country basis allowing you to make the most informed IRP decision for your products.

This report provides a rounded view of the applicable IRP rules across >100 markets via the following sections:

  • Global matrix demonstrating how countries are referencing each other, either formally or informally

  • Individual country tables providing high-level view into the applicable IRP rules at country-level

For more information about this report visit https://www.researchandmarkets.com/r/yme4qe

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900